Pharma Industrial India - Professional magazine for pharma industry suppliers and lab technology

India's Pharma Exports Set to Cross USD 30 Billion by Year-End: Dr Jitendra Singh

India’s pharma exports, currently valued at nearly USD 27.8 billion, are expected to cross USD 30 billion by the end of this year, Union Minister Dr. Jitendra Singh said.

Market | 01/10/2025 | By Dineshwori

Parexel Announces AI Partnership with Weave Bio to Accelerate Regulatory Submission Processes

Digitalization

More news

Pharma Industrial Magazine

All magazines | Subscribe

Interviews

From Reactive to Proactive: How AI is Redefining Regulatory Compliance in Pharma

Anirudh Ramachandra, Enterprise Sales Consultant at Findability Sciences

One of the biggest challenges faced by global pharmaceutical operations today is maintaining compliance across incredibly diverse regulatory markets, says Anirudh Ramachandra, Enterprise Sales Consultant at Findabil...

The Biggest Challenge Facing Indian Pharma Machinery Manufacturers Revealed

Milin Davar, Business Development Manager, Ace Technologies Group

Indian pharma machinery is finally getting recognition globally, with manufacturers establishing a strong presence in Southeast Asia, Africa, South America, and the Gulf countries. However, frequently changing regul...

Democratising Robotic Surgery: How SS Innovations is Breaking Barriers to Advanced Care

Dr. Vishwa Pascual Srivastava, MD & CEO - APAC, SS Innovations International

Robotic surgery adoption in India is rapidly growing, driven by increased awareness of its clinical benefits and the rise of cost-effective, indigenously developed platforms such as the SSI Mantra, says Dr. Vishwa P...

All interviews

Articles

Compressed Air Dryers: Key to Extending the Shelf Life of Critical Medicines

It is essential to deploy an efficient and reliable compressed air dryer throughout the pharmaceutical manufacturing process to eliminate all types of impurities from the compressed air, including water/moisture, du...

Supply Chain Security in Tier II and III Markets: Challenges and Solutions for Pharma Manufacturers

India's Tier II and III markets are seeing rapid growth in pharmaceutical demand, improving healthcare access, but also increasing risks like product diversion, unauthorised reselling, and counterfeit drugs—es...

Recalibrating Pharma after the GST Overhaul

The reform creates an opportunity for the pharma and medical device industry to advance affordable care, expand access to medicines and diagnostics, and improve insurance coverage....

All articles